Intestinal Permeability as a Clinical Surrogate Endpoint in the Development of Future Crohn's Disease Therapies

E-ISSN： 2212-2710|4|2|159-176

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.4, Iss.2, 2010-06, pp. : 159-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Applications of Autoimmunity to Citrullinated Proteins in Rheumatoid Arthritis, from Improving Diagnostics to Future Therapies

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 2, 2011-05 ,pp. : 108-127

Bentham Science Publishers

Access to resources Recommend Favorite

Antipsoriatic Drug Development: Challenges and New Emerging Therapies

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 3-21

Bentham Science Publishers

Access to resources Recommend Favorite

Current Prospective of Anti-IL-4, -IL-9, and -IL-13 Therapies in Allergic Disease

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 222-230

Bentham Science Publishers

Access to resources Recommend Favorite

Permeability Measurement

By Ivanov A.N. Kozlova S.N. Pechenov A.V.

Measurement Techniques, Vol. 43, Iss. 12, 2000-12 ,pp. : 1086-1088

Springer Publishing Company

Access to resources Recommend Favorite

State and Future Outlook for the Development of Hybrid Optical Image Converters

By Krutikov V.N.

Measurement Techniques, Vol. 45, Iss. 11, 2002-11 ,pp. : 1145-1152

Springer Publishing Company

Access to resources Recommend Favorite